PROFUSA, INC. Deferred Income Tax Expense (Benefit)
PROFUSA, INC. (PFSA) reported Deferred Income Tax Expense (Benefit) of -$5.53 million for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-05-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-05-01
- PROFUSA, INC. deferred income tax expense (benefit) for the quarter ending 2024-03-31 was -$13.66K.
- PROFUSA, INC. deferred income tax expense (benefit) for the quarter ending 2023-06-30 was -$1.34K.
- PROFUSA, INC. deferred income tax expense (benefit) for the quarter ending 2023-03-31 was -$35.60K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|
| 2025-12-31 | -$5.53M S-1/A · filed 2026-05-01 | ||
| 2024-12-31 | -$3.31M S-1/A · filed 2026-05-01 | ||
| 2024-03-31 | -$13.66K 10-Q · filed 2024-10-09 | ||
| 2023-06-30 | -$1.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$36.94K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$35.60K 10-Q · filed 2024-10-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |